# Cytek Biosciences, Inc.: Form 8-K, filed Sep 29, 2026

- Company: [Cytek Biosciences, Inc.](/companies/ctkb.md) (CIK 1831915)
- Form: 8-K
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 29, 2026, 16:06 ET
- Period: 2026-09-23
- Accession: 0001193125-26-407330
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1831915/000119312526407330/d94407d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1831915/000119312526407330/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1831915/000119312526407330/d94407d8k.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-407330. Last ingested by Listed: Nov 4, 2026, 18:49 ET. No prices; not investment advice.